title: Overexpression of integrin beta 5 enhances the paracrine properties of circulating angiogenic cells via Src kinase-mediated activation of STAT3.
abstract: OBJECTIVE
  To determine the intracellular mechanisms mediating the angiogenic effects of integrin alpha v beta 5 overexpression in circulating angiogenic cells (CACs).
  
  
  RESULTS
  Integrin alpha v beta 5 is expressed on angiogenic endothelial cells, and integrin alpha v beta 5 activation was shown to improve the reparative functions of endothelial progenitors within the cardiovascular system. CACs were transiently transfected with the full-length cDNA of human integrin beta 5 (CAC-ITGB5) or control-vector (CAC-vector). Integrin beta 5 overexpression was confirmed using flow cytometry, Western blot, and PCR analysis; it enhanced the angiogenic capacities of CACs in vitro (spheroid and Matrigel angiogenesis assay) and stimulated new vessel formation in vivo (murine hind limb ischemia model). Overexpression of ITGB5 resulted in integrin alpha v beta 5 phosphorylation and activation of Src kinase and signal transducer and activator of transcription (STAT) 3. Furthermore, elevated mRNA and protein expression of the CXC chemokine CXCL8 and the CC chemokine CCL2 was detected in CAC-ITGB5, and conditioned medium from CAC-ITGB5 enhanced the sprouting of coincubated human endothelial cells in a STAT3-, CXCL8-, and CCL2-dependent manner.
  
  
  CONCLUSIONS
  Src kinase-mediated activation of STAT3 and subsequent angiogenic gene expression mediate the effects of integrin alpha v beta 5 and may be exploited to enhance the paracrine activities of CACs.
authors.affiliation: Department of Cardiology and Pulmonology, Georg August University, Goettingen, Germany.
authors.forename: Maren
authors.initials: M
authors.lastname: Leifheit-Nestler
authors.forename: Gaby
authors.initials: G
authors.lastname: Conrad
authors.forename: Nana-Maria
authors.initials: NM
authors.lastname: Heida
authors.forename: Anne
authors.initials: A
authors.lastname: Limbourg
authors.forename: Florian P
authors.initials: FP
authors.lastname: Limbourg
authors.forename: Tim
authors.initials: T
authors.lastname: Seidler
authors.forename: Marco R
authors.initials: MR
authors.lastname: Schroeter
authors.forename: Gerd
authors.initials: G
authors.lastname: Hasenfuss
authors.forename: Stavros
authors.initials: S
authors.lastname: Konstantinides
authors.forename: Katrin
authors.initials: K
authors.lastname: Schäfer
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002448:Cell Adhesion; D002465:Cell Movement; D002478:Cells, Cultured; D018932:Chemokine CCL2 / Q000235:genetics / Q000378:metabolism; D017077:Culture Media, Conditioned / Q000378:metabolism; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000201:enzymology*; D004789:Enzyme Activation; D005434:Flow Cytometry; D006614:Hindlimb; D006801:Humans; D039641:Integrin beta Chains / Q000235:genetics / Q000378:metabolism*; D016209:Interleukin-8 / Q000235:genetics / Q000378:metabolism; D007511:Ischemia / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D051379:Mice; D008819:Mice, Nude; D018482:Muscle, Skeletal / Q000098:blood supply; D018919:Neovascularization, Physiologic; D019899:Paracrine Communication; D010766:Phosphorylation; D012333:RNA, Messenger / Q000378:metabolism; D019030:Receptors, Vitronectin / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D013997:Time Factors; D014162:Transfection; D015854:Up-Regulation; D019061:src-Family Kinases / Q000378:metabolism*
chemical_list: C111835:CCL2 protein, human; C508606:CXCL8 protein, human; D018932:Chemokine CCL2; D017077:Culture Media, Conditioned; D039641:Integrin beta Chains; D016209:Interleukin-8; D012333:RNA, Messenger; D019030:Receptors, Vitronectin; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C064660:integrin alphaVbeta5; C084344:integrin beta5; D019061:src-Family Kinases